A Win For iBio, Inc.
Wed, Dec 04, 2019 at 05:30 PM
iBio, Inc. (IBIO:NYSEMKT) soared at $0.28, representing a gain of 51.1%. On Tue 03 Dec 19, IBIO:NYSEMKT touched a New 2-Week High of $0.19. The stock got featured on our News Catalysts scanner on Mon 02 Dec 19 at 05:01 PM in the 'MISCELLANEOUS' category. From Tue 12 Nov 19, the stock recorded 28.57% Up Days and 26.67% Green Days
About iBio, Inc. (IBIO:NYSEMKT)
iBio Inc is a biotechnology company. It is engaged in commercializing its proprietary platform technologies, iBioLaunch for vaccines and therapeutic proteins & iBioModulator for vaccine enhancement and developing select product candidates.
Top 10 Gainers:
- Protagonist Therapeutics, Inc. (PTGX:NASDAQ), 72.92%
- iBio, Inc. (IBIO:NYSEMKT), 51.06%
- Kodiak Sciences Inc. (KOD:NASDAQ), 49.21%
- Allakos Inc. (ALLK:NASDAQ), 43.56%
- Jason Industries, Inc. (JASN:NASDAQ), 41.44%
- Anavex Life Sciences Corp. (AVXL:NASDAQ), 28.39%
- Comstock Mining Inc. (LODE:NYSEMKT), 27.71%
- Obsidian Energy Ltd. (OBE:NYSE), 22.55%
- Applied Therapeutics, Inc. (APLT:NASDAQ), 21.7%
- Neurotrope, Inc. (NTRP:NASDAQ), 21.3%